GOELTZ II ROBERT C. (Chief Financial Officer) received a stock award from ARCUS BIOSCIENCES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/26/2026ACC: 0001653881-26-000002
Officer· Chief Financial Officer
Since Aug 2020
+120K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
120K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+24K
Price / share
—
Trade value
—
% of position
35.3%
1/23/2026
67.92K→91.92K
Total
Net shares
+24K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/23/2026 | A · Award | +24K | — | — | 35.3% | 67.92K | 91.92K |
| Total | +24K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
96K shares
Shares
+96K
Strike price
22.13
Held after
96K
Exercisable
—
1/23/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock96K shares | 1/23/2026 | A · Award | +96K | 22.13 | — | 96K |